Skip to main content
Veterinary Medicines

IMIDOKAL 85 mg/ml solution for injection for cattle and dogs

Authorised
  • Imidocarb

Product identification

Medicine name:
IMIDOKAL 85 mg/ml solution for injection for cattle and dogs
Imidokal 85 mg/ml soluzione iniettabile per bovini e cani
Active substance:
  • Imidocarb
Target species:
  • Dog
  • Cattle
Route of administration:
  • Intravenous use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Imidocarb
    85.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
  • Intramuscular use
    • Dog
  • Subcutaneous use
    • Cattle
      • Meat and offal
        213
        day
    • Cattle
      • Milk
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51EX01
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Cardboard box with 1 vial of 50 ml
  • Cardboard box with 1 vial of 20 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Przedsiebiorstwo Wielobranzowe Vet-Agro Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Przedsiebiorstwo Wielobranzowe Vet-Agro Sp. z o.o.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105718
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0422/001
Concerned member states:
  • Ireland
  • Italy
  • Portugal

Documents

Combined File of all Documents

English (PDF)
Published on: 24/07/2025
Download
Italian (PDF)
Published on: 9/01/2024

Package Leaflet

English (PDF)
Published on: 27/06/2024
Download

Labelling

English (PDF)
Published on: 27/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."